Linkage Biosciences Inks European Distribution Deal With Voden | GenomeWeb

NEW YORK (GenomeWeb) – Linkage Biosciences today announced a distribution partnership with Voden Medical Instruments.

The deal gives Voden rights to distribute Linkage's genetic testing, including the real-time PCR-based LinkSeq human leukocyte antigen (HLA) test.

"Voden Medical possesses a long standing record of excellent customer service and proven technical expertise, particularly in the area of HLA testing," Linkage Biosciences CEO Zachary Antovich said in a statement.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.